Solubility Enhancement of a Poorly Soluble API
09 February 2006
Pierre Fabre Medicament - active ingredients division - will be exhibiting at INFORMEX (Stand #1342) and will give two presentations on the 14th of February :
11:20 am - 11:40 am : Technology Showcase
AN INNOVATIVE SOLUTION TO DEVELOP POORLY SOLUBLE APIS - BIOAVAILABILITY ENHANCEMENT
Pierre Fabre developed a technology enabling an API/Cyclodextrins complexation using SuperCritical CO2. The technology benefits are : developing poorly-soluble APIs, extending Product Life Cycle, developing oral formulations
2:20 pm - 2:40 pm : Exhibitor Showcase
PIERRE FARBRE CUSTOM MANUFACTURING SERVICES
Pierre Fabre is active in Cytotoxic APIs, Natural Product Extraction and Purification, Semisynthesis and Bioavailability enhancement. From Development to Commercial production in compliance with cGMPs.
Pierre Fabre Medicament - active ingredients division - will be participating to the following events :
INFORMEX : February, 14th-17th
BIOSQUARE : March, 8th-10th
BIOPHARMOS : March , 21st-22nd
